BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37730953)

  • 1. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
    Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH
    Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
    Kesby N; Mechera R; Fuchs T; Papachristos A; Gild M; Tsang V; Clifton-Bligh R; Robinson B; Sywak M; Sidhu S; Chou A; Gill AJ; Glover A
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2626-2634. PubMed ID: 36964913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
    Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
    [No Abstract]   [Full Text] [Related]  

  • 9. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
    Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
    World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
    J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
    Murat A; Modigliani E; Conte-Devolx B; Rohmer V; Leclerc L; Guilhem I; Bigorgne JC; Boneu A; Maes B; Chabre O; Niccoli P; Schuffenecker I; Giraud S
    Ann Chir; 1998; 52(5):455-60. PubMed ID: 9752487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
    Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
    Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
    Machens A; Lorenz K; Dralle H
    Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
    Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
    Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.
    Boschin IM; Torresan F; Toniato A; Zane M; Ide EC; Pennelli G; Rampin L; Colletti PM; Rubello D; Pelizzo MR
    Endocrine; 2014 Apr; 45(3):448-53. PubMed ID: 23884895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Lateral Neck Dissection for Medullary Thyroid Carcinoma is not Associated with Improved Survival.
    Spanheimer PM; Ganly I; Chou JF; Capanu M; Nigam A; Ghossein RA; Tuttle RM; Wong RJ; Shaha AR; Brennan MF; Untch BR
    Ann Surg Oncol; 2021 Oct; 28(11):6572-6579. PubMed ID: 33748897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
    Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
    World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.